-
Amring Pharmaceuticals Inc. Announces the Launch of Timolol Maleate Ophthalmic Solution, USP 0.5%
-June 20, 2022 BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it…
0 -
Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Lamotrigine Orally Disintegrating Tablets (ODT), USP
-February 14, 2022 02:47 PM Eastern Standard Time BERWYN, Pa.- Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical…
-
NORDIC PHARMA has acquired ALTIM® (cortivazol) pre-filled syringe to strengthen their Rheumatology portfolio
-Paris, January 2022 – NORDIC PHARMA is pleased to announce that they have entered into an agreement with SANOFI to…
-
Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer
-Nordic Pharma has announced that on 16 December 2021, the Committee for Medicinal Products for Human Use (CHMP) adopted a…
-
Amzell B.V. and Amring Pharmaceuticals Inc. Attending 2021 American Epilepsy Society Meeting in Chicago
-December 02, 2021 09:39 AM Eastern Standard Time BERWYN, Pa.–(BUSINESS WIRE)–Amzell B.V. (Amzell), a specialist development pharmaceutical company, and Amring…
-
Amzell, B.V., in Collaboration With Amring Pharmaceuticals Inc. Announce Their Lead Product Has Entered Phase III Clinical Trial in the U.S. for Treatment of Infantile Epileptic Disease
-Amzell, B.V., a specialty pharmaceutical development company based in The Netherlands, and Amring Pharmaceuticals Inc. (Amring), a niche brand and…
-
Sever Pharma Solutions acquires Foster Delivery Science
-Malmö, Sweden, November 5, 2021 — Sever Pharma Solutions (SPS), today announced it has entered into a definitive agreement to…
-
Amring Pharmaceuticals Inc. Licenses LYSTEDA to Pierre Fabre for Mexican Market
-BERWYN, Pa.–Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that on August 23, 2021 it…
-
Nordixate® Methotrexate Pre-filled Syringe approved in Colombia
-Nordic Pharma AAP is pleased to announce that the Nordixate® Methotrexate Pre-filled Syringe has been issued market authorization by Instituto…
-
Amring Pharmaceuticals Inc. announced Approval and Launch of Isoproterenol Hydrochloride
-BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA…
Press releases
Home > Press releases